Dr. YanYun Wu is the Chief Medical Officer of Bloodworks. As a member of the executive team, she provides medical oversight, guidance and policy direction for all of Bloodworks’s operations, as well as leadership for its specialized physicians and PhD lab directors. In addition, she provides operation oversight for clinical, medial and testing solutions, as well as biotherapy, including cell therapy. She is the medical director of Bloodworks immunohematology laboratory and the head of Bloodworks Academy.
Dr. Wu has been a faculty member of the Yale University School of Medicine since 2002. Prior to joining Bloodworks, Dr. Wu was the Associate Medical Director for Transfusion Service, Apheresis Service, and Cellular Therapy Laboratories at Yale-New Haven Hospital, Transfusion Medicine fellowship program director, and Associate Professor at Yale University School of Medicine. She continues her research studies in collaboration with many faculty members at Yale University as an adjunct Associate Professor. She is also an adjunct Professor at University of Washington. She promotes transfusion safety and quality practice in transfusion medicine and cellular therapy globally; in particular, she has been actively participating in transfusion medicine education in China. She holds several visiting faculty appointments in China including scholar professor at Peking Union Medical College.
Professionally Dr. Wu is an active member for many professional societies. Currently Dr. Wu is the President of the American Society for Apheresis (ASFA). She is the chair of the HPC committee of ABC. She is on the editorial board for the AABB publications and on the AABB committee for cell therapy circular of information. She is on the working group for standard coordination for cell therapy.